Central Venous Catheters Market Report 2026

The central venous catheters market size has grown strongly in recent years. It will grow from $4.3 billion in 2025 to $4.7 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing hospital admission rates, increased use of intravenous therapies, expansion of critical care services, rising demand for long-term vascular access, availability of standardized catheterization practices.

The central venous catheters market size is expected to see strong growth in the next few years. It will grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing focus on hospital-acquired infection reduction, rising adoption of advanced catheter materials, expansion of outpatient infusion services, growing demand for safer vascular access devices, increasing investments in patient safety technologies. Major trends in the forecast period include increasing use of antimicrobial-coated catheters, growing adoption of multi-lumen catheter designs, rising focus on infection prevention protocols, expansion of long-term vascular access solutions, enhanced training for catheter placement procedures.

The increasing incidence of kidney diseases is anticipated to drive the growth of the central venous catheter market in the coming years. The rising burden of kidney diseases is largely attributed to the growing prevalence of chronic conditions such as diabetes and hypertension, which often require interventions including the use of central venous catheters for critical treatments like dialysis. Central venous catheters play a vital role in kidney disease management by enabling reliable access for hemodialysis, medication delivery, nutritional support, and frequent blood sampling. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization, kidney disease was estimated to affect 7.19 million people in the UK in 2023, representing more than 10% of the population. This figure is projected to rise to 7.61 million by 2033, with the proportion of patients in later stages of the disease increasing from 45% to 51%. Therefore, the growing number of kidney disease cases is fueling the expansion of the central venous catheter market.

Major companies operating in the central venous catheter market are concentrating on the development of advanced ultrasound systems to improve accuracy and safety during catheter insertion procedures. Advanced ultrasound technologies enhance central venous catheter placement by offering real-time visualization, increasing placement precision, minimizing complications, and improving patient comfort and procedural efficiency. For instance, in November 2023, Becton, Dickinson and Company (BD), a US-based medical technology company, introduced SiteRite 9, an advanced vascular access ultrasound system designed to improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, intravenous lines, and other vascular access devices. The SiteRite 9 system features a 15.6-inch touchscreen interface with improved image clarity, incorporates the Cue needle tracking system for real-time needle guidance, and includes the Sherlock 3CG+ tip confirmation system for accurate catheter navigation. BD’s advanced ultrasound solution is designed to simplify vascular access procedures while supporting clinician productivity through intelligent, connected features such as vessel assessment and automated data capture.

In September 2024, Becton, Dickinson and Company completed the acquisition of the Critical Care business from Edwards Lifesciences for an undisclosed amount. Through this acquisition, BD aims to broaden its smart connected care portfolio, strengthen its presence in high-growth patient monitoring technologies, and enhance its offerings in advanced hemodynamic monitoring solutions used in intensive care and surgical environments. Critical Care, a division of Edwards Lifesciences, is a US-based provider of advanced patient monitoring systems, including central venous catheters.

Major companies operating in the central venous catheters market are Medtronic plc, Becton, Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Group Incorporated, ICU Medical Inc., Lepu Medical Technology (Beijing) Co. Ltd, Merit Medical Systems Inc, Vygon SAS, AngioDynamics Inc., Argon Medical Devices Inc., Poly Medicure Limited, Vogt Medical Vertrieb GmbH, MedCath Corporation, GaltNeedleTech Inc., Romsons International, Newtech Medical Devices Private Limited, NIPRO Medical Corporation, DemeTECH Corporation, Scitech Medical Products SA, Prodimed, P. K. Scientific & Chemicals.

North America was the largest region in the central venous catheters market in 2025. The regions covered in the central venous catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the central venous catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the central venous catheters market by increasing costs of imported medical-grade polymers, antimicrobial coatings, precision tubing, and sterilization materials. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to reliance on globally sourced catheter components, while Asia-Pacific faces cost pressures on imported finished devices. These tariffs are raising procurement costs and impacting supply planning. However, they are also encouraging local device manufacturing, regional material sourcing, and increased investment in domestic medical device production.

The central venous catheters market research report is one of a series of new reports that provides central venous catheters market statistics, including central venous catheters industry global market size, regional shares, competitors with a central venous catheters market share, detailed central venous catheters market segments, market trends and opportunities, and any further data you may need to thrive in the central venous catheters industry. This central venous catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Central venous catheters (CVCs) are medical devices placed into large veins to support long-term intravenous therapy, medication delivery, and blood sampling. They facilitate rapid administration of treatments, minimize the need for repeated needle insertions, and enable continuous patient monitoring, making them critical for managing complex medical conditions.

The main types in the central venous catheters market include single-lumen, double-lumen, triple-lumen, and others. Single-lumen central venous catheters are devices with a single channel that is inserted into a large vein to administer medications, fluids, or nutrients directly into the bloodstream. These catheters are available with properties such as antimicrobial-coated and non-antimicrobial-coated surfaces and are used across applications involving the jugular vein, subclavian vein, femoral vein, and others. The end users of these devices include hospitals, ambulatory surgical centers, and other healthcare settings.

The central venous catheters market consists of sales of standard CVCs, peripherally inserted central catheters (PICCs), implantable ports, and specialty CVCs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.